MIT Additive for PCR Master Mix Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PCR and RT-PCR technologies face challenges with non-specific priming and dimer-primer formation, leading to inefficiencies and resource depletion, particularly during master mix preparation, which affects assay performance and stability.
Innovation Solution
Incorporating 2-methyl-4-isothiazolin-3-one (MIT) into PCR and RT-PCR reactions to prevent non-specific priming and dimer-primer formation, enhancing the stability and performance of PCR and RT-PCR assays by reducing non-specific product accumulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If fast polymerase enzymes are used to increase PCR speed and processivity, then amplification speed is improved, but non-specific priming and dimer-primer formation increase
Solution Approach 1:
The patent introduces MIT as an intermediary substance that mediates between the fast polymerase enzyme and the primers. MIT selectively binds to non-specific primer complexes and dimer-primers, preventing their formation without interfering with specific target amplification. This allows the fast polymerase to maintain high speed while MIT acts as a protective agent against non-specific reactions.
Solution Approach 2:
The patent changes the chemical environment by introducing MIT, which alters the binding parameters of primer interactions. MIT modifies the local chemical conditions around the primers, making non-specific binding less favorable while preserving specific target binding. This parameter change enables differentiation between specific and non-specific priming events.
2Object-generated harmful factors
If hot start mechanisms are used to reduce non-specific priming, then specificity is improved, but reverse transcriptase enzymes are inactivated
Solution Approach 1:
MIT serves as an intermediary that provides hot start functionality without requiring thermal inactivation. Instead of using heat to prevent non-specific priming, MIT chemically suppresses non-specific binding at all temperatures, then selectively releases specific primers during amplification. This spares the reverse transcriptase enzyme from thermal denaturation while achieving the same specificity improvement.
Solution Approach 2:
The patent inverts the conventional hot start approach: instead of using heat to activate specific priming, MIT uses chemical suppression that is later relieved. The normal thermal cycling is retained, but the specificity control is achieved through MIT's temperature-independent binding properties rather than thermal activation.
3Productivity
If PCR master mixes are prepared in advance for manufacturing, then productivity is improved, but non-specific priming increases during storage
Solution Approach 1:
MIT is incorporated into the master mix during manufacturing as a preliminary protective action. The substance is pre-positioned in the reagent formulation to suppress non-specific priming throughout storage and handling. This preliminary inclusion of MIT ensures that when the master mix is later used, non-specific priming has already been prevented during the entire storage period.
Solution Approach 2:
MIT acts as a protective intermediary in the stored master mix, continuously suppressing non-specific primer interactions during storage. The substance maintains its protective function throughout the storage period, preventing the accumulation of non-specific products that would otherwise occur during extended storage of pre-prepared master mixes.
Data Source
AI summary
Provided herein is technology relating to amplification of nucleic acids and particularly, but not exclusively, to compositions and methods for doing improving the polymerase chain reaction and providing reagents for polymerase chain reaction with improved stability.